Medication errors in a children's inpatient antineoplastic chemotherapy facility

Area of Science:

• Pediatric Oncology
• Patient Safety
• Medication Management

Background:

• Antineoplastic drugs pose risks due to toxicity and narrow therapeutic windows.
• Medication errors are a significant concern for pediatric oncology patients.
• This study addresses medication errors in a pediatric inpatient chemotherapy setting.

Purpose of the Study:

• To identify and classify medication errors in pediatric inpatient chemotherapy.
• To evaluate the outcomes associated with these medication errors.

Main Methods:

• Retrospective observational study over 5 months.
• Review of 286 medical records in a pediatric chemotherapy facility.
• Medication errors classified using the International Classification for Patient Safety.

Main Results:

• 962 medication errors identified, with a rate of 3.36 errors per visit.
• Most errors occurred during documentation (66.8%) and administration (23.6%).
• 37.2% of errors had potential for injury; only 0.5% reached the patient, with 0.2% causing severe harm.

Conclusions:

• Medication errors are common in pediatric chemotherapy, especially in documentation.
• Enhanced documentation strategies are needed to reduce near misses.
• Preventing documentation errors can mitigate potential adverse events.